Atara Biotherapeutics Inc. (ATRA) Stock Price

40.14 ▲ +0.60 (+1.52%)
Open: 40.73 Vol: 17.36K Day's range: 39.42 - 40.73 Dec 18, 10:04 EST
IEX Real-Time Price
Free Stock Screener
Loading chart ...
ATRA Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 39.83▲ 39.86▲ 39.81▲ 41.29▼ 40.04▲
MA10 39.69▲ 39.81▲ 40.04▲ 41.21▼ 38.06▲
MA20 39.69▲ 40.11▲ 41.35▼ 39.96▲ 38.61▲
MA50 39.37▲ 41.65▼ 41.68▼ 37.33▲ 39.77▲
MA100 40.86▼ 41.57▼ 40.91▼ 38.19▲ 27.65▲
MA200 41.72▼ 40.71▼ 38.64▲ 40.12▲ 28.01▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.066▲ 0.118▲ -0.207▼ -0.116▼ 0.228▲
RSI 58.766▲ 45.725▼ 42.587▼ 52.095▲ 53.229▲
STOCH 31.061     62.912     48.135     60.185     68.086    
WILL %R -44.697     -19.667▲ -51.471     -55.120     -28.776    
CCI 134.582▲ 103.318▲ -33.373     -56.693     31.506    
Latest Filters Detected On ATRA
CDL $ATRA Harami Candlestick Pattern Detected Set Alert
▲ GAP $ATRA Open Gap Up %2 Set Alert
▲ GAP $ATRA Open Gap Up %3 Set Alert
MA $ATRA Price Crossed Above MA(200) Set Alert
▼ MACD $ATRA MACD(12,26,9) Crossed Below Signal Line Set Alert
Atara Biotherapeutics Inc. News
Atara Biotherapeutics Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma
Monday, December 17, 2018 10:34 AM
Atara Biotherapeutics (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases ...
Atara Biotherapeutics Presents Positive Efficacy and Safety Results for Patients with Epstein-Barr Virus-Associated Leiomyosarcoma (EBV+ LMS)
Saturday, December 15, 2018 04:00 AM
Dec. 15, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, aut...
Targeting 'bubble baby' disease, this gene therapy company is planting a flag in the East Bay
Thursday, December 13, 2018 11:18 AM
Meanwhile, Emeryville's Gritstone Oncology Inc. (NASDAQ: GRTS) and other cell therapy companies, including Atara Therapeutics Inc. (NASDAQ: ATRA) and Gilead Sciences Inc. (NASDAQ: GILD), are construct...
ATRA historical stock data
date open high low close volume
18/12/18 40.73 40.73 39.42 40.14 17,361
17/12/18 41.20 41.20 37.05 39.54 552,594
14/12/18 42.05 43.36 41.50 41.72 353,661
13/12/18 42.80 43.38 42.28 42.61 674,333
12/12/18 42.68 43.58 42.14 42.45 556,512
11/12/18 43.67 43.9336 41.35 42.36 361,813
10/12/18 40.50 43.225 40.00 42.97 599,824
07/12/18 39.74 41.38 39.74 40.20 424,963
06/12/18 39.82 40.68 38.70 39.67 428,568
04/12/18 42.50 43.935 40.40 40.45 670,739
Quote Details
Bid:37.79
Ask:41.44
52wk Low:14.805
52wk High:54.45
Vol:17.36K
Avg Vol(3m):9.5M
1Y Chng:+116.97%
1M Chng:+6.93%
Add to Watch List
More Information
Index NASDAQ Composite
Market Cap. 1.90B